Page 287 - Eshre Final Programme 2015

P-742 The contribution of FSH receptor polymorphism on ovarian response and treatment efficiency following stimulation with FE 999049, a recombinant FSH from a human cell-line
J.C. Arce1
1Ferring Pharmaceuticals, Global Clinical R&D (Reproductive Health), Copenhagen, Denmark
P-743 To evaluate which factors determine the incidence of extremely elevated progesterone on the day of HCG administration
Y.R. Tsai1, K.C. Lan1
1Kaohsiung Chang Gung Memorial Hospital, Department of Obstetrics and Gynecology Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City, Taiwan R.O.C.
P-744 The effect of LH-activity components contained in HMG on the clinical outcomes during progestin- primed ovarian stimulation in normalovulatory women undergoing IVF/ICSI treatments compared with u-FSH
X.X. Zhu1, Q.J. Chen1, A. Ai1, Y.L. Fu1, R.F. Cai1, H. Tian1, Y. Wang1, Q.Q. Hong1, Q.F. Lyu1, Y.P. Kuang1
1Shanghai Ninth People's Hospital, Department of Assisted Reproduction, Shanghai, China
FINAL PROGRAMME I LISBON, PORTUGAL – 14 TO 17 JUNE 2015 287
POSTERS